Head-down Position for Acute Ischemic Stroke With Large Artery Atherosclerosis
HOPES2
1 other identifier
interventional
96
1 country
1
Brief Summary
Currently, the guideline recommended re-perfusion such as intravenous thrombolysis and mechanical thrombectomy as the most effective treatment for acute ischemic stroke. However, the two methods are restricted by a strict time window, which greatly limits the number of the patients receiving treatment. The abundant studies have suggested that good collateral circulation can provide compensatory blood supply to save the ischemic penumbra and reduces the infarct volume, which improves the prognosis. How to improve collateral circulation in an efficient and safe way is a clinical challenge. Our recent experiment results of the animal and preliminary clinical experiments show that head-down position may significantly increase cerebral perfusion and improve neurological function. Clinically, head-down position is simple and easy to operate, and theoretically may increases brain perfusion and improve collateral circulation. A pilot randomized clinical trial is designed to investigate the effect of head-down position combined with routine rehabilitation in patients with ischemic stroke.The study is designed to explore the efficacy and safety of head-down position in patients with acute ischemic stroke
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2018
CompletedFirst Posted
Study publicly available on registry
November 16, 2018
CompletedStudy Start
First participant enrolled
November 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 28, 2021
CompletedSeptember 28, 2021
September 1, 2021
2.8 years
November 14, 2018
September 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
proportion of modified Rankin Score of 0 to 2
90 days
Secondary Outcomes (4)
Proportion of modified Rankin Score of 0 to 1
90 days
proportion of early neurological deterioration
48 hours
The occurence of stroke or other vascular events
90 days
proportion of death of any cause
90 days
Study Arms (2)
head-down position treatment
EXPERIMENTALguideline-based treatment
ACTIVE COMPARATORInterventions
the head position of subjects is lowered to 20 degrees in a supine position between 8:00-22:00 within 24h post-randomization as long as possible. During the procedure, when subjects feel intolerable, the head position will be elevated to lying flat (0 degree) for 5-10min, and then the above procedure is repeated. After 24h post-randomization, the head down procedures with -20 degrees in a supine position with duration of 1-1.5 hour will be performed three times daily at 9:00-11:00, 15:00-17:00 and 20:00-22:00, respectively.
guideline-based treatment
Eligibility Criteria
You may qualify if:
- Patient age over 18 years
- acute ischemic stroke within 24 h of onset
- neurological deficit: 6≤NIHSS≤16
- Large artery atherosclerosis etiology based on TOAST typing
- the supplied vessel is the middle cerebral artery or internal carotid artery, and the degree of stenosis was more than 50%.
- first stroke onset or past stroke without obvious neurological deficit (mRS≤1)
- Signed informed consent
You may not qualify if:
- Disturbance of consciousness
- Hemorrhagic stroke or mixed stroke
- Combining with severe organ dysfunction
- Past hemorrhagic stroke
- A history of stroke with severe sequelae
- Planned revascularization within 3 months
- Ischemic stroke due to surgical intervention
- participating in other clinical trials within 3 months
- Pregnant or lactating women
- any inappropriate patient assessed by the researcher
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
General Hospital of ShenYang Military Region
Shenyang, China
Related Publications (1)
Chen HS, Zhang NN, Cui Y, Li XQ, Zhou CS, Ma YT, Zhang H, Jiang CH, Li RH, Wan LS, Jiao Z, Xiao HB, Li Z, Yan TG, Wang DL, Nguyen TN. A randomized trial of Trendelenburg position for acute moderate ischemic stroke. Nat Commun. 2023 May 5;14(1):2592. doi: 10.1038/s41467-023-38313-y.
PMID: 37147320DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Huisheng Chen, Doctor
Neurology Department
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department Chairman
Study Record Dates
First Submitted
November 14, 2018
First Posted
November 16, 2018
Study Start
November 26, 2018
Primary Completion
August 28, 2021
Study Completion
August 28, 2021
Last Updated
September 28, 2021
Record last verified: 2021-09